Patent · US Active

Identifying individual target sites for transcranial magnetic stimulation applications

US10137307B2 · kind B2 · utility

5Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2013
Grant dateNov 27, 2018
Priority date
Expiry dateMar 15, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2/02
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Techniques for identifying individual target sites for application of transcranial magnetic stimulation (TMS) to a brain of a patient for treatment of neurological and psychiatric disorders. The identification of the target TMS stimulation sites may be based on using functional connectivity magnetic resonance imaging (fMRI) to determine cortex regions of the brain that are functionally connected to other regions of the brain that may be stimulated to decrease symptoms of depression and other disorders. For example, target stimulation sites may be identified in the left dorsolateral prefrontal cortex (DLPFC) to remotely modulate the activity in a subgenual cingulate region and other limbic regions functionally connected with the DLPFC. TMS may be applied to the patient's head at the identified target TMS sites to treat depression and other neurological and psychiatric disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.